Cargando…

Secreted TRAIL gene‐modified adipose‐derived stem cells exhibited potent tumor‐suppressive effect in hepatocellular carcinoma cells

OBJECTIVE: Considering the potential of adipose‐derived stem cells (ADSCs) migrating towards cancer cells, this study was performed to explore the function of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) modified ADSCs on the development and progression of hepatocellular carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhuo, Li, Shaojie, Ma, Tiexiang, Zeng, Jian, Zhou, Xin, Li, Huanyu, Tang, Min, Liu, Xiang, Li, Feng, Jiang, Bin, Zhao, Ming, Chen, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860607/ https://www.ncbi.nlm.nih.gov/pubmed/33156578 http://dx.doi.org/10.1002/iid3.372

Ejemplares similares

iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
por: Dong, Yanbing, et al.
Publicado: (2023)

Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
por: Dong, Yanbing, et al.
Publicado: (2023)

MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression
por: Zhou, Xin, et al.
Publicado: (2021)

A Risk Model Based on Sorafenib-Response Target Genes Predicts the Prognosis of Patients with HCC
por: Liu, Xiang, et al.
Publicado: (2022)

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021)

GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay
por: Cao, Guozheng, et al.
Publicado: (2022)

New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells
por: Cen, Ling, et al.
Publicado: (2009)

Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
por: Liu, Zhuo, et al.
Publicado: (2022)

TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma in vitro and in vivo
por: Chen, Yidan, et al.
Publicado: (2020)

Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells
por: Mao, Chenyu, et al.
Publicado: (2015)

Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma
por: Jiang, Honglei, et al.
Publicado: (2017)

Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
por: Ehrhardt, H, et al.
Publicado: (2013)

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
por: Liang, Chaojie, et al.
Publicado: (2017)

Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes
por: Flusberg, Deborah A., et al.
Publicado: (2013)

Inhibition of cyclinB1 Suppressed the Proliferation, Invasion, and Epithelial Mesenchymal Transition of Hepatocellular Carcinoma Cells and Enhanced the Sensitivity to TRAIL-Induced Apoptosis
por: Lv, Shuai, et al.
Publicado: (2020)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Potent Suppression of Kv1.3 Potassium Channel and IL-2 Secretion by Diphenyl Phosphine Oxide-1 in Human T Cells
por: Zhao, Ning, et al.
Publicado: (2013)

Aplysin Sensitizes Cancer Cells to TRAIL by Suppressing P38 MAPK/Survivin Pathway
por: Liu, Jia, et al.
Publicado: (2014)

Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
por: Yu, Xinfang, et al.
Publicado: (2017)

TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas
por: Zhang, Huanyu, et al.
Publicado: (2021)

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
por: Lin, Li, et al.
Publicado: (2010)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition
por: WANG, XIAOFEI, et al.
Publicado: (2011)

Adipose-derived mesenchymal stem cell-facilitated TRAIL expression in melanoma treatment in vitro
por: JING, HAI XIA, et al.
Publicado: (2016)

Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis
por: Zhang, Zhenjiang, et al.
Publicado: (2020)

Senescence-secreted factors activate Myc and sensitize pretransformed cells to TRAIL-induced apoptosis
por: Vjetrovic, Jelena, et al.
Publicado: (2014)

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells
por: van Vliet, Amanda A., et al.
Publicado: (2023)

Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs
por: Cheng, Chieh-Fang, et al.
Publicado: (2013)

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma
por: Wang, Yigang, et al.
Publicado: (2015)

Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells
por: Mehbuba Hossain, Sultana, et al.
Publicado: (2018)

TSG101 Silencing Suppresses Hepatocellular Carcinoma Cell Growth by Inducing Cell Cycle Arrest and Autophagic Cell Death
por: Shao, Zhuo, et al.
Publicado: (2015)

Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects
por: Pan, Yufei, et al.
Publicado: (2023)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Letter to the Editor on “Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL”
por: Liu, Mingli
Publicado: (2017)

Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells
por: Zhang, Shuijun, et al.
Publicado: (2012)

The tumor suppressive effect and apoptotic mechanism of TRAIL gene‐containing recombinant NDV in TRAIL‐resistant colorectal cancer HT‐29 cells and TRAIL‐nonresistant HCT116 cells, with each cell bearing a mouse model
por: Jung, Bo‐Kyoung, et al.
Publicado: (2023)

B7-H3 specific CAR-T cells exhibit potent activity against prostate cancer
por: Li, Shibao, et al.
Publicado: (2023)

Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL
por: Jeong, Moonsup, et al.
Publicado: (2009)

Combined Treatment of Cinobufotalin and Gefitinib Exhibits Potent Efficacy against Lung Cancer
por: Han, Youxi, et al.
Publicado: (2021)

Tissue Inhibitor of Matrix Metalloproteinases-1 Knockdown Suppresses the Proliferation of Human Adipose-Derived Stem Cells
por: Zhang, Peihua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4ugasckotsh5dh84j959paj6in